NASDAQ
Evaxion Biotech A/S (EVAX) has a interest coverage ratio of -10.54x as of Friday, May 29, 2026. This represents a 50.42% increase compared to its 12-month average of -21.26x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.